| Literature DB >> 26713218 |
Michael Jermyn1, Yoann Gosselin2, Pablo A Valdes3, Mira Sibai4, Kolbein Kolste5, Jeanne Mercier2, Leticia Angulo2, David W Roberts6, Keith D Paulsen5, Kevin Petrecca7, Olivier Daigle8, Brian C Wilson4, Frederic Leblond9.
Abstract
In glioma surgery, Protoporphyrin IX (PpIX) fluorescence may identify residual tumor that could be resected while minimizing damage to normal brain. We demonstrate that improved sensitivity for wide-field spectroscopic fluorescence imaging is achieved with minimal disruption to the neurosurgical workflow using an electron-multiplying charge-coupled device (EMCCD) relative to a state-of-the-art CMOS system. In phantom experiments the EMCCD system can detect at least two orders-of-magnitude lower PpIX. Ex vivo tissue imaging on a rat glioma model demonstrates improved fluorescence contrast compared with neurosurgical fluorescence microscope technology, and the fluorescence detection is confirmed with measurements from a clinically-validated spectroscopic probe. Greater PpIX sensitivity in wide-field fluorescence imaging may improve the residual tumor detection during surgery with consequent impact on survival.Entities:
Keywords: (170.3890) Medical optics instrumentation; (170.6280) Spectroscopy, fluorescence and luminescence
Year: 2015 PMID: 26713218 PMCID: PMC4679278 DOI: 10.1364/BOE.6.005063
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732